Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals

By LabMedica International staff writers
Posted on 02 Feb 2026

Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care. More...

However, many laboratory teams lack the structured training needed to translate these data into actionable insights. Until now, no program had offered a comprehensive overview of how data science can be applied in the clinical laboratory. To address this gap, the Association for Diagnostics & Laboratory Medicine (ADLM) has launched its Data Science in Laboratory Medicine Certificate Program.

ADLM’s Data Science in Laboratory Medicine Certificate Program is designed to help clinical laboratory professionals and pathologists use healthcare data to solve challenging patient problems. Through curated real-world examples, participants learn core data science concepts and practical tools to improve testing algorithms, reduce errors, enhance laboratory operation efficiency, and collaborate more effectively with local data analysts. 

Developed by a team of ADLM’s data science experts, the program provides a foundational overview of key data analytics approaches and how they are applied in laboratory medicine and pathology to strengthen professional expertise and clinical impact. The program covers best practices related to data science, ranging from healthcare data security to mitigation of lab data problems, in addition to the use of machine learning in laboratory workflows.

"We are thrilled to launch this new certificate program for laboratory medicine professionals and pathologists who want to stay ahead of the emerging developments in data science," said ADLM President Dr. Paul J. Jannetto. "Our members saw the need for a professional program that would not only address foundational data science education, but that would also raise awareness of the value of data analytics in laboratory medicine. Healthcare professionals who complete this program will be uniquely distinguished in a field increasingly driven by data and analytics."

Related Links
Association for Diagnostics & Laboratory Medicine (ADLM)


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.